Home
Conditions
Leukemia, Basophilic, Acute

Clinical trial condition

Leukemia, Basophilic, Acute

Explore clinical trials studying Leukemia, Basophilic, Acute. Study availability and eligibility vary by location and protocol.

42 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Basophilic, Acute trial results

Completed

Tipifarnib, Cytarabine, and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia

NCT00101153

Conditions: Bone Marrow Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations: McMaster Children's Hospital at Hamilton Health Sciences Hamilton, Ontario, Canada

London Regional Cancer Program at London Health Sciences Centre London, Ontario, Canada

View Trial Details

Completed

Sorafenib in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndromes, or Blastic Phase Chronic Myelogenous Leukemia

NCT00217646

Conditions: Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia, +52 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Tipifarnib and Bortezomib in Treating Patients With Acute Leukemia or Chronic Myelogenous Leukemia in Blast Phase

NCT00383474

Conditions: Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia, +49 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Completed

S0112 Cytarabine and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia

NCT00023777

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
Locations: MBCCOP - Gulf Coast Mobile, Alabama, United States

CCOP - Greater Phoenix Phoenix, Arizona, United States

Veterans Affairs Medical Center - Phoenix (Carl T. Hayden) Phoenix, Arizona, United States

Veterans Affairs Medical Center - Tucson Tucson, Arizona, United States

View all 98 locations

View Trial Details

Completed

S0106B Studying Bone Marrow Samples From Women With Acute Myeloid Leukemia

NCT01575535

Conditions: Bone Marrow Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations: Not specified

View Trial Details

Completed

Idarubicin, Cytarabine, and Tipifarnib in Treating Patients With Newly Diagnosed Myelodysplastic Syndromes or Acute Myeloid Leukemia

NCT00096122

Conditions: Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7), +47 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Arsenic Trioxide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia

NCT00093483

Conditions: Bone Marrow Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Cytarabine With or Without VNP40101M in Treating Patients With Relapsed Acute Myeloid Leukemia

NCT00112554

Conditions: Bone Marrow Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations: USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States

Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States

Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center Orange, California, United States

UCSF Comprehensive Cancer Center San Francisco, California, United States

View all 62 locations

View Trial Details

Completed

Cladribine, Cytarabine, and Imatinib Mesylate in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Blastic Phase Chronic Myelogenous Leukemia

NCT00258271

Conditions: Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +21 more
Locations: James P. Wilmot Cancer Center at University of Rochester Medical Center Rochester, New York, United States

View Trial Details

Completed

Tanespimycin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Chronic Myelomonocytic Leukemia, or Myelodysplastic Syndromes

NCT00098423

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, +58 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Leukemia, Basophilic, Acute

Leukemia, Basophilic, Acute trial results

Related conditions